Lipophilicity in Drug Development: Too Much or Not Enough?

Area of Science:

• Pharmaceutical Sciences
• Medicinal Chemistry

Background:

• A round table discussion at the AAPS Annual Meeting (October 27, 2015) addressed the role of lipophilic compounds in drug development.
• The session fostered idea exchange between academic and industry scientists, attracting over 250 participants.

Framework:

• The core debate centered on whether an increase or decrease in lipophilic compounds is beneficial for drug discovery.
• Key discussion points included the varying approaches to compound selection and development strategies across different organizations.

Implementation:

• The round table served as a platform for scientists to share diverse perspectives on optimizing drug development pipelines.
• Feedback indicated the session was highly valuable for its interactive and informative nature.

Implications:

• The dialogue underscored the critical need for continued debate on selecting optimal drug development candidates.
• Effective candidate selection is crucial for enabling efficient drug delivery and successful disease treatment.